1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,900 | 2,940 | 10:01 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GUSHENGTANG Aktie jetzt für 0€ handeln | |||||
| 31.08. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 28.08. | Gushengtang Holdings Limited Reveals Rise In H1 Bottom Line | - | RTTNews | ||
| 28.08. | GUSHENGTANG 1H26 Net Profit Climbs 45.4% to RMB221M; Interim DPS Surges ~2.3x to HKD1.15 | 1 | AASTOCKS | ||
| 28.08. | GUSHENGTANG Rallies 11% in Heavy PM Trading after Interim Profit Jumps 45%, Interim DPS Up ~2.3x | 5 | AASTOCKS | ||
| 28.08. | GUSHENGTANG (02273): DECLARATION AND PAYMENT OF INTERIM DIVIDEND FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND CLOSURE OF REGISTER OF MEMBERS | 1 | HKEx | ||
| 28.08. | GUSHENGTANG (02273): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 2 | HKEx | ||
| 27.08. | GUSHENGTANG (02273): VOLUNTARY ANNOUNCEMENT - ACQUISITIONS OF 100% EQUITY INTERESTS IN THE TARGET COMPANIES | - | HKEx | ||
| 18.08. | GUSHENGTANG (02273): DATE OF BOARD MEETING | 1 | HKEx | ||
| 23.07. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 16.07. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 10.07. | Gushengtang Steps Up TCM Buying Spree, Doubling Down In Beijing | 1 | Benzinga.com | ||
| 08.07. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 30.06. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 24.06. | Dividendenbekanntmachungen (24.06.2026) | 10.759 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AH REALTY TRUST INC US04208T1088 0,14 USD 0,1229 EUR AMBEV SA ADR US02319V1035 0,0091 USD 0,008 EUR ARLANDASTAD GROUP AB SE0016276851 1... ► Artikel lesen | |
| 23.06. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 23.06. | GUSHENGTANG (02273): VOLUNTARY ANNOUNCEMENT - ACQUISITIONS OF EQUITY INTERESTS IN TARGET COMPANIES | 1 | HKEx | ||
| 18.06. | GUSHENGTANG (02273): ELEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION | - | HKEx | ||
| 18.06. | GUSHENGTANG (02273): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 18, 2026 | 1 | HKEx | ||
| 15.06. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 08.06. | GUSHENGTANG (02273): NEXT DAY DISCLOSURE RETURN | 1 | HKEx |
1 2 3 Weiter >>
54 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 57,88 | 0,00 % | BrightSpring auf Wells Fargo Konferenz: Wachstum beschleunigt sich auf breiter Front | ||
| TENON MEDICAL | 5,340 | +0,75 % | Morning Market Movers: Tenon Medical, Shoe Station, Cooper Companies, Culp, Inc. See Big Swings | TOKYO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,760 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| AVEANNA HEALTHCARE | 13,860 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,370 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| ADAPTHEALTH | 5,850 | 0,00 % | Truist reiterates Buy on AdaptHealth stock after CFO change | ||
| PROGYNY | 27,080 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| HEARTFLOW | 45,470 | -0,04 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,000 | 0,00 % | LifeStance prices 22.3 million share secondary offering at $12.35 | ||
| PROCEPT BIOROBOTICS | 20,070 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| BILLIONTOONE | 98,67 | +0,16 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 83,97 | +0,01 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,590 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PACS GROUP | 44,820 | -0,04 % | Truist reiterates Buy on PACS Group stock after Florida deal | ||
| CLEARPOINT NEURO | 13,480 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen |
GUSHENGTANG HOLDINGS LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,040 (-1,36 %) liegt der Kurs bei 2,900 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GUSHENGTANG HOLDINGS LTD finden Sie auf Wallstreet Online.